A case of Cushing s syndrome in pregnancy secondary to an adrenal cortical adenoma. by Kim, Hwi Gon et al.
INTRODUCTION
Pregnancy rarely occurs in women with Cushing’s syn-
drome(CS), because both excessive cortisol and androgen
levels suppress gonadotropin secretion and impair ovarian
and endometrial functions. CS usually presents with hyper-
tension and diabetes, so it may give rise to increase  mater-
nal and fetal morbidity, including high rates of miscarriage
or premature delivery. Here we report a case of CS in preg-
nancy secondary to an adrenal cortical adenoma, which was
diagnosed after delivery and treated with laparoscopic adre-
nalectomy.
CASE REPORT
A 30-yr-old pregnant woman gravida two para one at 30
weeks of gestation was referred and admitted in March 31
2001, because of the difficulty of controlling hypertension
and cushingoid features. She had been diagnosed the gesta-
tional diabetes at 27 weeks’ gestation by the 100-gram oral
glucose tolerance test, and had been controlled through the
diet control. She experienced preeclampsia in her previous
pregnancy and was delivered by cesarean operation. 
Physical examination revealed with some features of CS,
including moon face, truncal obesity, muscular atrophy,
purple striae on the abdomen, hyperpigmentation over pres-
sure areas and acne. Her blood pressure in hospital ranged
from 150/100 to 190/120 mmHg. She was administered
with intravenous hydralazine, but her blood pressure was
not controlled. 
Her blood sugar level after admission was 106 mg/dL due
to diet control. Urinary dipstick test revealed significant pro-
teinuria (+++). Except for mild increased serum GOT/GPT
(57/100 U/L), other laboratory abnormalities were not found.
Fetal ultrasonography revealed a single viable fetus with
normal morphology and parameters. Diastolic pressure of
umbilical artery was nearly absent and RI was checked at
0.97. The fetal heart rate monitoring disclosed a loss of vari-
ability. Because of severe preeclampsia and compromised
fetal status, emergency cesarean operation was performed. A
1,220-gram female baby with Apgar scores of 6 at 1 min and
8 at 5 min was delivered. The neonatal course was compli-
cated by a moderate respiratory distress syndrome requiring
artificial surfactant. The baby was discharged 3 months later
in a good condition. 
A provisional diagnosis of CS in pregnancy with gestational
diabetes was made after delivery because of some clinical
features of CS above described, and plasma cortisol, 24-hr
urinary free cortisol and plasma ACTH, the plasma cortisol
response to low- and high-dose dexamethasone suppression
tests was measured. Her morning and evening plasma corti-
sol levels were 26.3  g/dL (normal: 5-25  g/dL) and 34.6
g/dL (normal: half of the morning level), respectively. 24
hr urinary free cortisol were 409.5 nmol/day (normal: 55-
248 nmol/day), and were not suppressed with low-dose or
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Cushing’s syndrome in pregnant women is rare and difficult to be diagnosed
because of the syndrome's association with oligomenorrhea or amenorrhea and
the changes in cortisol metabolism during normal pregnancy. Cushing syndrome
in pregnancy is usually confused with complicated pregnancy, such as preeclamp-
sia or gestational diabetes, and its rarity leads to a low degree of clinical suspi-
cion, often delaying diagnosis. We experienced a case of Cushing’s syndrome
in pregnancy, which had been considered as the severe preeclampsia and ges-
tational diabetes due to uncontrolled hypertension and hyperglycemia. The preg-
nancy was terminated with an emergency cesarean operation at 30 weeks of
gestation because of severe preeclampsia. In consequence of the evaluation
about the Cushing’s syndrome after delivery, the adrenal cortical adenoma of
right adrenal gland was diagnosed and laparoscopic adrenalectomy was per-
formed. 
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Accepted : 8 July 2002high-dose dexamethasone loading. ACTH level was 2-14
pg/mL (normal: 10-60 pg/mL). Abdominal CT detected a
3-cm sized right adrenal mass (Fig. 1). The final diagnosis
was CS in pregnancy secondary to an adrenal tumor. The
patient underwent a laparoscopic right adrenalectomy. Patho-
logic examination showed a benign adrenocortical adenoma. 
Maintenance steroid replacement was continued postop-
eratively until now because of impaired adrenal function.
DISCUSSION
The occurrence of pregnancy in the face of untreated CS is
rare because of the high incidence of ovulatory disturbances
experienced by patients with the disorder. In 1953, Hunt
and McConahey (1) first reported several cases of pregnancy
associated with untreated Cushing syndrome. Since then
Buescher et al. (2) reviewed a total of 58 patients with 65
pregnancies associated with CS in the world literature and
found that 50% of these cases were caused by adrenal ade-
noma, in contrast to 15.7% in nonpregnant women. In 1998,
Murakami et al. (3) showed similar results that the benign
adrenocortical adenoma was found in about half of pregnan-
cy with CS, but the most common cause of CS in nonpreg-
nant women was pituitary-dependent adrenal hyperplasia.
This difference may be related to the mechanism of ovula-
tion suppression. In other words, the patient with pituitary-
dependent CS could due mainly to a disturbed gonadotropic
axis, such as cosecretion of prolactin, but the patients with
an adrenal adenoma are more likely to be purely cortisol-
producing, allowing women to retain more often their ovu-
latory function (2-4).
CS is a disease associated with high mortality rates, esti-
mated at 50% at 5 yr when the disease is untreated. CS in
pregnancy follows a hazardous course with an increased inci-
dence of abortion, premature labor, hypertension, gestation-
al diabetes, cardiac failure and even pulmonary edema (2, 3,
5). It is therefore not surprising that the maternal morbidity
in CS is excessive.
Hypertension and glucose intolerance are common mater-
nal complications. Their incidences are reported as high as
58.8% and 25.0%, respectively (3). In this case, blood pres-
sure was also very high and was not controlled by intravenous
hydralazine administration. Although the maternal glucose
level in this patient was not so high at the time of admis-
sion, postpartum blood glucose level ranged from 110 mg/
dL to 240 mg/dL. This may be owing to the patient’s strict
diet control during antepartum period.
Fetal complications are also severe. Preterm deliveries, be-
tween 22 and 36 gestational weeks, were associated with half
of pregnancies. Intrauterine growth retardation (IUGR) oc-
curred in 13.2% and perinatal deaths were 8.8% of the preg-
nancies (3). Fetal weight in this case was 1,220-gram, so IUGR
was not marked, considering that the gesational age was 30
weeks. 
If the etiology of CS is adrenal adenoma, the therapeutic
alternatives are unilateral adrenalectomy during pregnancy
or medical treatment with operation performed after delivery
(6, 7). The ideal timing for an adrenalectomy is not known,
but most obstetricians and surgeons consider the second
trimester to be suitable as the pregnancy is relatively more
stable during this period (8). This patient was treated with
laparoscopic adrenalectomy after delivery because the diag-
nosis was made after cesarean operation. Successful medical
treatment of hypercortisolism secondary to an adrenal ade-
noma during pregnancy with metyrapone or ketoconazole
has also been reported (9). However, metyrapone crosses the
placenta and may affect fetal adrenal steroid synthesis, and
ketoconazole is teratogenic and embryotoxic in animals (10).
This treatment could be an alternative for poor surgical can-
didates or be used to stabilize patients prior to operation. 
We believe that CS complicating pregnancy is a high-risk
obstetric condition. Definitive treatment during pregnancy
may not alter the perinatal outcome except for a reduction
in the prematurity rates. During the third trimester, early
delivery of the fetus, with delay of definite therapy until after
delivery, may be the most prudent course. Vaginal delivery
is preferable to cesarean operation because of the problems
with poor tissue healing and wound breakdown. Therapy
must be indivisualized between a definitive surgical approach
versus alleviation of hypercortisolism using chemotherapy.
There is no logical phase for supportive therapy alone because
maternal and perinatal outcomes are unacceptably poor in
the face of untreated Cushing syndrome. 
Conclusively, CS in pregnancy requires a high index of
suspicion because of its rarity, therefore CS is worthy of being
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Fig. 1. Abdominal CT showing a right adrenal mass (arrow).
5 
cmconsidered when a pregnant woman develops high blood
pressure and/or hyperglycemia. Otherwise, both mother and
fetus may have poor outcomes, since the diagnosis is delayed
and treatment is not instituted in a timely manner.
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